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DefectAbstract Background: Arsenic is an important environmental toxicant which is usually found in
drinking water in inorganic form. Arsenic exposure in pregnant mice causes neural tube defects
(NTDs). Chlorpyrifos, an organophosphorus insecticide, recommended universally and in Egypt
to control various pests, was evaluated for its potential developmental toxicity. Studies have shown
increasing evidence to suggest an association between environmental exposure to this agricultural
pesticides and adverse reproductive outcomes. The hypothesis tested in this investigation is chlor-
pyrifos causes significant defects on the developing central nervous system compared to the proven
Arsenic.
Objectives: The aim of this work was to assess congenital malformations induced by the
organophosphorus insecticide chlorpyrifos on the neural tube and brain development in compar-
ison with the positive control Arsenic.
Methods: Virgin female ICR (CD-1) mice, approximately 10 weeks old were mated with adult
males. The day the vaginal plug was found was considered day 0 of gestation. It consisted of
320 mice. They were subdivided into four groups of 80 bred mice each. Each group was divided into
4 subgroups, and 20 mice per each were treated by gavage as follows: 30 mg/kg/day chlorpyrifos
(tested group), 40 mg/kg/day sodium Arsenite (positive control group), and corn oil and distilled
water (negative control groups) on days 6–15 of gestation. Maternal observations throughout ges-
tation were reported. In each subgroup the mice proved to be pregnant were sacrificed on gesta-
tional days; GD 10, 11, 12 and 16. The day of scarification was determined according to the
neural tube developmental stages. The conceptus extraction was done and their number reported
to be subjected to the SEM study.
Table 1 The number of mice embr
12 and 16 of development randomly
Study groups
Number of embryos examined in each
Day 10 of development
Day 11 of development
Day 12 of development
Day 16 of development
a Corn oil as a vehicle of chlorpyrifo
b Distilled water as a vehicle of Arse
c Arsenic as Sodium Arsenite (40 mg
* Significantly different from contro
** Significantly different from contro
360 M.R.R.F. Abdelmalek et al.After mice scarification, the uteri were opened and a total of 30 embryos and fetuses, randomly
selected from each subgroup were processed for scanning electron microscopy investigating the neu-
ral tube developmental defects.
Results: CPF ingested by gravid mice at dose of 30 mg/kg/day started from 6th day of gestation
proved to produce NTDs as compared to Arsenite.
Conclusion: Neural tube defects are due to chlorpyrifos that may directly influence brain cell repli-
cation and differentiation.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Despite restriction on production for home use, chlorpyrifos
(CPF), [O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl)-phosphoro
thioate], remains one of the most widely used insecticides, and
there is concern over the potential consequences of fetal and
childhood exposure.1–5 Uses of CPF, as indoor pests, were
restricted in June 2000.5,6 Despite this restriction CPF is still
widely used as indoor pesticide and pet collars in Egypt.
Immature organisms are more susceptible to CPF induced tox-
icity than adults.7,8 The presence of CPF residue in the umbil-
ical cord and its association with decreases in fetal growth
among women during pregnancy raises question about the sen-
sitivity of residue parameter of CPF.8 Furthermore, it has been
emphasized that perinatal exposure of women to CPF would
lead to shortening of the gestational period.9 In addition, sev-
eral studies have reported that repeated exposure to CPF dur-
ing gestation can cause fetotoxicity and marked neurochemical
changes in the developing brain.10–13 Chlorpyrifos exposure
during the perinatal period is known to evoke deficits in neu-
ritic outgrowth, specifically including the target of cholinergic
projections.14,15 Exposure of pregnant female mice to 30 mg/
kg/day CPF through 6–15 days of gestation resulted in
increase of gestation length and post implantation loss,
decreased litter size and weight, and survivability.16,17 It is
questionable whether malformations produced by a dose of
30 mg/kg/day, particularly neural tube defects, could be
increased. Therefore, the present study was conducted to assess
the ability of CPF to cause brain and neural tube defects at a
dose of 30 mg/kg/day CPF compared to Sodium Arseniteyos and fetuses with neural fold f











l at P 6 0.05.
l at P 6 0.01.which was used as a positive control and confirmed to produce
developmental toxicity and neural tube defects.18–202. Material and methods
320 female ICR (CD-1) mice, approximately 10 weeks old,
were mated. The gravid mice were subdivided into four
groups of 80 bred mice each. Each group was divided into
4 subgroups, and 20 mice per each were treated by gavage
as follows: 30 mg/kg/ day chlorpyrifos (tested group),
40 mg/kg/day sodium arsenite (positive control group),
and corn oil and distilled water (negative control
groups) on days 6–15 of gestation. On GD 10, 11, 12
and 16, after mice scarification, the uteri were opened
and a total of 30 embryos and fetuses, randomly selected
from each subgroup were processed for scanning electron
microscopy investigation.213. Results of the scanning electron microscopic (SEM) study
Study of the neural fold fusion with SEM was done in the
chlorpyrifos and sodium arsenite treated groups in mice
embryos on gestational days GD10, 11, 12 and in mice fetuses
on day 16 of development and compared to the controls
(Table 1, Figs. 1–4).
On day 10 of development, examination of embryo speci-
mens showed that the neural folds in the control groups
approached each other and the neural groove became concave
for the completion of closure of the neural tube. At the sameusion disruption as evident by SEM examination on days 10, 11,
ups of the study.
Negative control (2)b Positive controlc Chlorpyrifos 30 mg/kg/d
30 30 30
0 (0) 6 (16)* 9 (30)**
0 (0) 7 (23)* 10 (33)**
0 (0) 8 (26)* 11 (37)**











Figure 1 Scanning electron micrograph of the dorsal view of cranial end of the neural tube of mouse embryo on day 10 of development
showing: (a) Normal apposition of the neural folds (NF) delineating narrow linear groove in the negative control. SEM 150. (b)
Separated edges of the neural folds (NF) delineating a wide linear groove in the sodium arsenite group. SEM 150. (c) More separated
edges of the neural folds (NF) delineating a wider linear groove in the chlorpyrifos group. SEM 150.
Study of the effect of chlorpyrifos on the neural tube 361stage in the chlorpyrifos treated group, the neural folds were
still away from each other and had an irregular crumpled
appearance in 9 out of 30 (30% of) embryos, showing a signif-
icant delay in initiation of neural tube closure. Also the posi-
tive control sodium Arsenite mice group showed delay in
neural tube fusion compared to its negative control in only 6
(16%) of embryos (Table 1, Fig. 1a–c).
On day 11 of development, in both of the two control
groups, the neural folds showed progressive opposition of each
other along their full length and the neural tube was almost
closed in all embryos. At the same stage in the chlorpyrifos
treated group the neural tube was still widely opened in ten
(33%) of mouse embryos compared to its corresponding neg-
ative control group. Similarly in the Sodium Arsenite group,
the neural tube was opened in only 7 (23%) of mouse embryos
compared to its corresponding negative control group indicat-
ing a delay in neural tube development (Table 1, Fig. 2a–c).On day 12 of development, mice embryos of the control
groups had a completely closed neural tube. At the same stage
the neural tube was still opened in 11 (40%) and 8 (26%) of
mice embryos in the chlorpyrifos treated group and the
Sodium Arsenite treated group respectively compared to their
corresponding negative controls indicating a significant
increase in neural tube closure defect compared to the negative
controls (Table 1, Fig. 3a–c).
On day 16 of development of the mouse fetus, an opening
in the head was observed in 12 (40%) in the chlorpyrifos group
and 9 (30%) in the Sodium Arsenite group compared to their
corresponding negative controls (Table 1).
The lateral view of mice embryos on day 11 of development
showed an overall delay of neural development in both chlor-
pyrifos and Sodium Arsenite treated groups to the two nega-
tive control groups. A less distinct optic vesicle and otic










Figure 2 Scanning electron micrograph of dorsal view of mouse embryo on day 11 of development showing: (a) Almost closed neural
tube through complete apposition of the neural folds (NF) in the negative control group. SEM 100. (b) Partially opened neural tube
through separated neural folds (NF) in the sodium arsenite group. SEM 100. (c) Partially opened neural tube through separated and
averted neural folds (NF) in the chlorpyrifos group. SEM 100.
362 M.R.R.F. Abdelmalek et al.of the head and limb buds were noted in both chlorpyrifos and
Sodium Arsenite treated groups compared to their correspond-
ing negative control groups (Fig. 4a–c).
The lateral view of mice embryos on day 12 of development
showed more developmental delay of different nervous tissues.
The head was not well developed in the chlorpyrifos treated
group with exencephaly, and in the Sodium Arsenite group
compared to the negative controls. The nasal pits showed
delayed development in both treated groups compared to the
negative controls. Also the limb plates did not show digital
rays and circular constrictions in both treated groups com-
pared to the negative controls (Fig. 5a–c).4. Discussion
Chlorpyrifos itself is a developmental neurotoxicant due to the
ability of its metabolite chlorpyrifos-oxon to inhibit cholines-terase. Although biologic effects of chlorpyrifos are attributed
to the biotransformation to chlorpyrifos-oxon and other
metabolites that act to inhibit a cholinesterase, CPF disrupted
maturation of sea urchin embryos during the specific period
during which development is regulated by neurotrophic
factors.23 Recent evidence suggests that chlorpyrifos itself
may directly influence brain cell replication and differentia-
tion.11–13 Chlorpyrifos has immediate direct inhibitory actions
on DNA synthesis and hence on neural cell replication, with
preferential targeting of gliotypic cells.22 Therefore, chlorpyri-
fos may induce damage by both noncholinergic and choliner-
gic mechanisms extending from early stages of neural cell
replication through late stages of axonogenesis and terminal
differentiation.24
CPF itself is a developmental neurotoxicant above inhibi-
tion of cholinesterase by its metabolite, chlorpyrifos-oxon.11
The most thoroughly investigated hypothesis is that fetal brain










Figure 3 Scanning electron micrograph of dorsal view of mouse embryo on day 12 of development showing: (a) The neural folds
completely fused along their full length in the negative control group. SEM 75. (b) Partially opened neural tube through separated neural
folds (NF) in the sodium arsenite group. SEM 75. (c) Partially opened neural tube through separated neural folds (NF) in the
chlorpyrifos. SEM 75.
Study of the effect of chlorpyrifos on the neural tube 363pyrifos dosages. The exceptional recovery capacity of fetal
brain cholinesterase may represent a form of protection, but
ultimately the pesticide still inhibits cholinesterase activity in
the fetal brain. The inhibition of fetal brain cholinesterase,
even intermittently, may be deleterious to the coordinated
development of the brain given the postulated novel role for
the cholinesterases in nervous system development. The inhibi-
tion of AChE caused by CPF is more persistent than that
caused by other organophosphates. This result may be attrib-
uted to the high lipophilicity of chlorpyrifos.22
In the electron microscopic study of the present work, cra-
nial neural fold development of the control embryos and
fetuses showed a morphogenetic pattern generally similar to
those described in previous studies. NTDs were concentrated
on the fusion process of the neural folds in mouse embryos
as a basis for a better understanding of closure defects andwere able to show the precise steps of fusion in rat, hamster
and mouse embryos.25 The delay in timing of neural fold
fusion in this study for both chlorpyrifos and Arsenic may
be a reflection of hypoplasia and a general retardation of
development of the neural tube when compared with negative
control embryos on the same days of gestation. Moreover a
delay in development in the different developing systems and
exencephaly was observed. These findings are similar to those
previously reported.25,26 Putz and Morriss-Kay also reported
an abnormal neural fold development with exencephaly in
mouse embryos with triosomy 12 and triosomy 14.26
Chlorpyrifos may directly influence brain cell replication
and differentiation and has immediate direct inhibitory actions
on DNA synthesis and hence on neural cell replication. There-
fore, chlorpyrifos may induce damage by both noncholinergic











Figure 4 Scanning electron micrograph of lateral view of mouse embryo on day 11 of development showing: (a) The head folded with a
large size of the head, optic vesicle (OV) and otic placode (OP) and with the limb buds (LB) and a tail (T) in the negative control group.
SEM 50. (b). Small and malformed folded head with optic vesicle and otic placode not apparent and with the limb buds (LB) not well
developed and somites (S) in the sodium arsenite group. SEM 50. (c) Cranial malformation as anencephaly (A) with the limb buds (LB)
not well developed and somites (S) in the chlorpyrifos group. SEM 50.
364 M.R.R.F. Abdelmalek et al.neural cell replication through late stages of axonogenesis and
terminal differentiation.12,13,24
Several recent studies suggest that chlorpyrifos affects rel-
atively early and late events in brain development. These
studies focused around the proliferation, differentiation, and
functioning of glial cell, the cells that provide metabolic sup-
port for neurons and that guide axons to their proper targets
within the developing central nervous system.27 In addition,
Lassiter et al. (1998) and White et al. (2002) found that pre-
natal chlorpyrifos exposure can disrupt architectural organi-
zation of specific subregions, including apoptosis and
changes in cell migration.24,28 In turn, these findings raise
the issue of identifying the critical window for adverse effects
of chlorpyrifos on neurodevelopment. If late-occurring pro-
cesses are involved, then vulnerability will extend into child-
hood, a period in which exposures may be particularly
high.29–315. Conclusion
Chlorpyrifos showed fetotoxicity at a maternal dose of 30 mg/
kg per day in the form of neural tube defects. This is due to
chlorpyrifos that may directly influence brain cell replication
and differentiation. Although restriction of indoor use has
been recommended, CPF is still used at least as pesticide with
hazardous environmental pollution. Females living in areas
with high risk of this pollution are more susceptible to give
births with neurological deficits so it is highly recommended
to restrict the use of CPF also as pesticide and as anti-flea in
pet collars.
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Figure 5 Scanning electron micrograph of lateral view mouse embryo on day 12 of development showing: (a) The embryo tightly C
shaped, has nasal pit (NP) and the fore- and hindlimb plates (LP) in the negative control group. SEM 50. (b) Small sized and partially
undifferentiated head, not well apparent nasal pit (NP) and the limb plates (LP) are not well developed in the sodium arsenite group. SEM
50. (c) Exencephaly (E), not well apparent nasal pit and the limb plates (LP) are not developed in the chlorpyrifos group. SEM 50.
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